Management of Asymptomatic Hyperammonemia (≈ 90 µmol/L)

Age‑Specific Normal Ranges

• In neonates, normal plasma ammonia is < 110 µmol/L (1–7 days), < 90 µmol/L (8–14 days), and 16–53 µmol/L from 15 days to adulthood; therefore a value of 90 µmol/L may be within the upper normal range for infants < 15 days old【1】.

Clinical Decision‑Making Based on Symptoms

• Treatment decisions are driven primarily by the presence of neurological manifestations (e.g., encephalopathy, lethargy, confusion, coma) rather than by the absolute ammonia concentration; asymptomatic patients with a level of 90 µmol/L generally do not require ammonia‑lowering therapy【2】【1】.

Monitoring and Sample Handling

• If clinical concern persists, repeat the ammonia measurement after 24–48 hours, using properly collected free‑flowing venous or arterial blood that is placed on ice and analyzed within 15 minutes to avoid artifactual elevation【1】.
• Ongoing observation for new neurological signs (confusion, lethargy, asterixis, altered mental status) should prompt escalation of care【2】【1】.
• Correct sample collection techniques are essential because mishandling can produce falsely high ammonia results and lead to unnecessary interventions【1】.

Criteria for Escalation of Therapy

• Continuous kidney replacement therapy (CKRT) is recommended when ammonia rises above 300–400 µmol/L despite medical management or when there is neurological deterioration【2】.
• In the setting of rapid neurological decline with ammonia > 150 µmol/L, immediate initiation of CKRT is advised【2】.

Nutritional Management

• Protein restriction is not indicated for asymptomatic patients with ammonia ≈ 90 µmol/L; restriction is reserved for levels ≥ 150 µmol/L【1】.

Special Pediatric Considerations

• For patients younger than 15 days, a measured ammonia of 90 µmol/L may be normal and does not warrant intervention unless symptoms develop【1】.

Treatment Thresholds for Hyperammonemia

Introduction to Hyperammonemia Management

• The American Academy of Pediatrics and other medical societies recommend initiating nitrogen-scavenging agents at ammonia levels >150 μmol/L and considering kidney replacement therapy at levels >300-400 μmol/L, particularly with neurological deterioration 3, 4

Treatment Algorithm Based on Ammonia Level

• For patients with mild elevation (upper limit of normal to 150 μmol/L), stop all protein intake immediately and initiate intravenous glucose and lipids to prevent catabolism, with a target caloric intake ≥100 kcal/kg daily 3, 5
• For moderate elevation (>150 μmol/L), begin nitrogen-scavenging therapy immediately with intravenous sodium benzoate and sodium phenylacetate, and add L-arginine hydrochloride and L-carnitine as needed 3, 4, 5, 6
• For severe elevation (>300-400 μmol/L or rapid rise), initiate continuous kidney replacement therapy (CKRT) or intermittent hemodialysis, and continue nitrogen scavengers concurrently 4, 6

Critical Monitoring Requirements

• Collect ammonia samples from free-flowing venous or arterial blood, transport on ice, and process within 15 minutes to avoid falsely elevated results, and check plasma ammonia every 3-4 hours until normalized 3, 7, 6

Protein Reintroduction

• Reintroduce protein within 48 hours maximum once ammonia decreases to 80-100 μmol/L to prevent catabolism, starting at 0.25 g/kg/daily and gradually increasing up to 1.5 g/kg/daily 3, 5, 7

Common Pitfalls to Avoid

• Do not use lactulose for urea cycle disorders or non-hepatic hyperammonemia, as it is ineffective and delays definitive treatment, and do not delay dialysis while waiting for medical management alone at levels >400 μmol/L with neurological symptoms 5, 6